MarketBeat Instant News Alerts 2 hours agoHC Wainwright Reaffirms Buy Rating for Celldex Therapeutics (NASDAQ:CLDX)MarketBeatHC Wainwright reiterated a "buy" rating and issued a $64.00 price objective on shares of Celldex Therapeutics in a research report on Friday.NASDAQ:CLDXRead HC Wainwright Reaffirms Buy Rating for Celldex Therapeutics (NASDAQ:CLDX)2 hours agoForward Air (NASDAQ:FWRD) Price Target Cut to $25.00 by Analysts at SusquehannaMarketBeatSusquehanna dropped their price objective on Forward Air from $29.00 to $25.00 and set a "positive" rating on the stock in a research note on Friday.NASDAQ:FWRDRead Forward Air (NASDAQ:FWRD) Price Target Cut to $25.00 by Analysts at Susquehanna2 hours agoGXO Logistics (NYSE:GXO) Given New $60.00 Price Target at SusquehannaMarketBeatSusquehanna lowered their target price on GXO Logistics from $62.00 to $60.00 and set a "positive" rating for the company in a research note on Friday.NYSE:GXORead GXO Logistics (NYSE:GXO) Given New $60.00 Price Target at Susquehanna2 hours agoMagnite's (MGNI) Buy Rating Reaffirmed at Rosenblatt SecuritiesMarketBeatRosenblatt Securities reissued a "buy" rating and set a $40.00 price target on shares of Magnite in a report on Friday.NASDAQ:MGNIRead Magnite's (MGNI) Buy Rating Reaffirmed at Rosenblatt Securities2 hours agoOpus Genetics (NASDAQ:IRD) Earns Buy Rating from Chardan CapitalMarketBeatChardan Capital restated a "buy" rating and issued a $16.00 target price on shares of Opus Genetics in a research report on Friday.NASDAQ:IRDRead Opus Genetics (NASDAQ:IRD) Earns Buy Rating from Chardan Capital2 hours agoSusquehanna Issues Pessimistic Forecast for Canadian National Railway (NYSE:CNI) Stock PriceMarketBeatSusquehanna reduced their target price on shares of Canadian National Railway from $142.00 to $130.00 and set a "neutral" rating for the company in a report on Friday.NYSE:CNIRead Susquehanna Issues Pessimistic Forecast for Canadian National Railway (NYSE:CNI) Stock Price Trending News1Rivian Eyes Late-Year Autonomy Rollout as R2 Production Ramp Takes Center Stage2Aurora Innovation (NASDAQ:AUR) Shares Down 6.7% - Here's Why3Intel (NASDAQ:INTC) Shares Down 5.7% - Here's Why4QuantumScape (NYSE:QS) Shares Down 6.4% - Here's What Happened5USA Rare Earth (NASDAQ:USAR) Stock Price Down 5% - Here's What Happened6Rocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's Why7IREN (NASDAQ:IREN) Stock Falls 1.2% on Analyst Downgrade8Oracle (NYSE:ORCL) Stock Rating Reaffirmed as Buy by Sanford C. Bernstein All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoLineage (NASDAQ:LINE) Stock Price Target Lowered at ScotiabankMarketBeatNASDAQ:LINERead Lineage (NASDAQ:LINE) Stock Price Target Lowered at Scotiabank2 hours agoSusquehanna Issues Pessimistic Forecast for Canadian Pacific Kansas City (NYSE:CP) Stock PriceMarketBeatNYSE:CPRead Susquehanna Issues Pessimistic Forecast for Canadian Pacific Kansas City (NYSE:CP) Stock Price2 hours agoCSX (NASDAQ:CSX) Given New $55.00 Price Target at SusquehannaMarketBeatNASDAQ:CSXRead CSX (NASDAQ:CSX) Given New $55.00 Price Target at Susquehanna2 hours agoAcuity (NYSE:AYI) Issues Earnings Results, Beats Estimates By $0.20 EPSMarketBeatNYSE:AYIRead Acuity (NYSE:AYI) Issues Earnings Results, Beats Estimates By $0.20 EPS2 hours agoIntegra LifeSciences (NASDAQ:IART) Releases Q3 2026 Earnings GuidanceMarketBeatNASDAQ:IARTRead Integra LifeSciences (NASDAQ:IART) Releases Q3 2026 Earnings Guidance2 hours agoIntegra LifeSciences (NASDAQ:IART) Releases FY 2026 Earnings GuidanceMarketBeatNASDAQ:IARTRead Integra LifeSciences (NASDAQ:IART) Releases FY 2026 Earnings Guidance2 hours agoPenguin Solutions (NASDAQ:PENG) Earns "Buy" Rating from Rosenblatt SecuritiesMarketBeatNASDAQ:PENGRead Penguin Solutions (NASDAQ:PENG) Earns "Buy" Rating from Rosenblatt Securities2 hours agoMiami International (NYSE:MIAX) Earns "Buy" Rating from Rosenblatt SecuritiesMarketBeatNYSE:MIAXRead Miami International (NYSE:MIAX) Earns "Buy" Rating from Rosenblatt Securities2 hours agoRosenblatt Securities Issues Positive Forecast for Synaptics (NASDAQ:SYNA) Stock PriceMarketBeatNASDAQ:SYNARead Rosenblatt Securities Issues Positive Forecast for Synaptics (NASDAQ:SYNA) Stock Price2 hours agoNIKE's (NKE) "Hold" Rating Reiterated at Needham & Company LLCMarketBeatNYSE:NKERead NIKE's (NKE) "Hold" Rating Reiterated at Needham & Company LLC2 hours agoRobert W. Baird Has Lowered Expectations for Fair Isaac (NYSE:FICO) Stock PriceMarketBeatNYSE:FICORead Robert W. Baird Has Lowered Expectations for Fair Isaac (NYSE:FICO) Stock Price2 hours agoNautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Has Average Price Target of $3.83MarketBeatNASDAQ:NAUTRead Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Has Average Price Target of $3.832 hours agoCPB Inc. (NYSE:CPF) Stock Now Rated "Moderate Buy" by Wall Street AnalystsMarketBeatNYSE:CPFRead CPB Inc. (NYSE:CPF) Stock Now Rated "Moderate Buy" by Wall Street Analysts2 hours agoPimco Corporate & Income Opportunity Fund (NYSE:PTY) Shares Will Pay Monthly Dividend of $0.12MarketBeatNYSE:PTYRead Pimco Corporate & Income Opportunity Fund (NYSE:PTY) Shares Will Pay Monthly Dividend of $0.122 hours agoBank OZK (NASDAQ:OZK) Increases Dividend to $0.49 Per ShareMarketBeatNASDAQ:OZKRead Bank OZK (NASDAQ:OZK) Increases Dividend to $0.49 Per Share2 hours agoNIKE (NYSE:NKE) Given New $50.00 Price Target at BTIG ResearchMarketBeatNYSE:NKERead NIKE (NYSE:NKE) Given New $50.00 Price Target at BTIG Research2 hours agoonsemi (NASDAQ:ON) Earns Buy Rating from Needham & Company LLCMarketBeatNASDAQ:ONRead onsemi (NASDAQ:ON) Earns Buy Rating from Needham & Company LLC2 hours agoAbbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co RedburnMarketBeatNYSE:ABTRead Abbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co Redburn2 hours agoServiceTitan (NASDAQ:TTAN) Earns Buy Rating from BTIG ResearchMarketBeatNASDAQ:TTANRead ServiceTitan (NASDAQ:TTAN) Earns Buy Rating from BTIG Research2 hours agoHC Wainwright Reaffirms Buy Rating for LSI Industries (NASDAQ:LYTS)MarketBeatNASDAQ:LYTSRead HC Wainwright Reaffirms Buy Rating for LSI Industries (NASDAQ:LYTS)2 hours agoAccenture (NYSE:ACN) Price Target Raised to $195.00MarketBeatNYSE:ACNRead Accenture (NYSE:ACN) Price Target Raised to $195.002 hours agoHC Wainwright Reaffirms "Buy" Rating for Connect Biopharma (NASDAQ:CNTB)MarketBeatNASDAQ:CNTBRead HC Wainwright Reaffirms "Buy" Rating for Connect Biopharma (NASDAQ:CNTB)2 hours agoAnadarko Petroleum (NASDAQ:APC) Raised to "Outperform" at MizuhoMarketBeatNASDAQ:APCRead Anadarko Petroleum (NASDAQ:APC) Raised to "Outperform" at Mizuho2 hours agoCullinan Therapeutics' (CGEM) "Buy" Rating Reiterated at HC WainwrightMarketBeatNASDAQ:CGEMRead Cullinan Therapeutics' (CGEM) "Buy" Rating Reiterated at HC Wainwright Featured Articles and OffersDeutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?By Sam Quirke | September 30, 2026How Elon’s Empire Ends (and how to profit)From Chaikin Analytics (Ad)Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?By Chris Markoch | September 28, 2026Data Centers Got the AI Hype—But Office REITs May Get the Rent HikesBy Chris Markoch | September 27, 2026Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-OutBy Thomas Hughes | September 29, 2026Larry Benedict's Top Ticker Watch Before the Fed's September 16 DecisionFrom Brownstone Research (Ad)CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBy Thomas Hughes | September 29, 2026Everyone in AI Is Quietly Copying Palantir's PlaybookBy Chris Markoch | October 1, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 187 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
